About Athens General Hospital 'G Gennimatas
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
G.Gennimatas General Hospital
4
Eli Lilly and Company
2
Hoffmann-La Roche
2
Protagonist Therapeutics, Inc.
2
Amgen
1
Horizon Therapeutics Ireland DAC
1
Spyridon Deftereos
1
Takeda
1
Viela Bio (acquired by Horizon Therapeutics)
1
Clinical Trials at Athens General Hospital 'G Gennimatas
During the past decade, Athens General Hospital 'G Gennimatas conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL)
2010-09-30
2012-07-31
Completed
1,288
Moxonidine for Prevention of Post-ablation AFib Recurrences
2012-08-01
2014-04-01
Completed
150
OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on Dialysis
2013-07-15
2016-09-04
Completed
437
A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease
2014-12-30
2020-07-17
Completed
207
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
2017-11-28
2023-06-30
Active, not recruiting
454
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Athens General Hospital 'G Gennimatas" #1 sponsor was "G.Gennimatas General Hospital" with 4 trials, followed by "Eli Lilly and Company" with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Protagonist Therapeutics, Inc." with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Athens General Hospital 'G Gennimatas"
#1 collaborator was "Academy of Athens" with 1 trials as a collaborator, "Evangelismos Hospital" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Athens General Hospital 'G Gennimatas
According to Clinical.Site data, the most researched conditions in "Athens General Hospital 'G Gennimatas" are
"Acute Myocardial Infarction" (2 trials), "Anemia" (2 trials), "Atrial Fibrillation" (2 trials), "Ineffective Erythropoiesis" (2 trials) and "β-thalassemia" (2 trials). Many other conditions were trialed in "Athens General Hospital 'G Gennimatas" in a lesser frequency.
Clinical Trials Intervention Types at Athens General Hospital 'G Gennimatas
Most popular intervention types in "Athens General Hospital 'G Gennimatas" are "Drug" (11 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Colchicine" (2 trials), "PTG-300" (2 trials), "Tirzepatide" (2 trials) and "Apremilast" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Athens General Hospital 'G Gennimatas
The vast majority of trials in "Athens General Hospital 'G Gennimatas" are
15 trials for "All" genders.
Clinical Trials Status at Athens General Hospital 'G Gennimatas
Currently, there are NaN active trials in "Athens General Hospital 'G Gennimatas".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 7 completed trials in Athens General Hospital 'G Gennimatas,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Athens General Hospital 'G Gennimatas, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 1 trials that are defined as “Not Applicable".